FDA Moves to Ease Cuffless Blood Pressure Device Rules as Vital Signals Seeks Clearance

In January 2026 the FDA began crafting broader regulatory exemptions for cuffless, non-invasive blood pressure devices using optical heart rate monitors. Vital Signals, founded by ex-Android engineer Tom Moss, is pursuing FDA clearance for its $399 Signal Ring in that category, with the long-term goal of insurer partnerships for preventative care.